Search Results - "TERCEL, Moana"
-
1
Conjugation of Palbociclib with MHI-148 Has an Increased Cytotoxic Effect for Breast Cancer Cells and an Altered Mechanism of Action
Published in Molecules (Basel, Switzerland) (27-01-2022)“…The CDK4/6 inhibitor palbociclib, combined with endocrine therapy, has been shown to be effective in postmenopausal women with estrogen receptor-positive,…”
Get full text
Journal Article -
2
Clinical relevance and therapeutic predictive ability of hypoxia biomarkers in head and neck cancer tumour models
Published in Molecular oncology (01-08-2024)“…Tumour hypoxia promotes poor patient outcomes, with particularly strong evidence for head and neck squamous cell carcinoma (HNSCC). To effectively target…”
Get full text
Journal Article -
3
Spatially-resolved pharmacokinetic/pharmacodynamic modelling of bystander effects of a nitrochloromethylbenzindoline hypoxia-activated prodrug
Published in Cancer chemotherapy and pharmacology (01-10-2021)“…Purpose Hypoxia-activated prodrugs (HAPs) have the potential for eliminating chemo- and radiation-resistant hypoxic tumour cells, but their activity is often…”
Get full text
Journal Article -
4
Engineering the Escherichia coli Nitroreductase NfsA to Create a Flexible Enzyme-Prodrug Activation System
Published in Frontiers in pharmacology (07-06-2021)“…Bacterial nitroreductase enzymes that can efficiently convert nitroaromatic prodrugs to a cytotoxic form have numerous applications in targeted cellular…”
Get full text
Journal Article -
5
Nitro-chloromethylbenzindolines: hypoxia-activated prodrugs of potent adenine N3 DNA minor groove alkylators
Published in Molecular cancer therapeutics (01-10-2009)“…Hypoxia represents an important therapeutic target in tumors because of the resistance of hypoxic cells to radiotherapy and chemotherapy and because it is more…”
Get full text
Journal Article -
6
Hypoxic selectivity and solubility—investigating the properties of A-ring substituted nitro seco-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-ones (nitroCBIs) as hypoxia-activated prodrugs for antitumor therapy
Published in Bioorganic & medicinal chemistry (15-07-2010)“…Nitro seco-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-ones (nitroCBIs) are a new class of prodrugs for antitumor therapy that undergo hypoxia-selective…”
Get full text
Journal Article -
7
Optimised synthesis of a nitroCBI hypoxia-activated prodrug with substantial anticancer activity
Published in Tetrahedron (31-05-2019)“…An optimised synthesis of a hypoxia-activated anticancer prodrug related to the duocarmycin family of natural products is described. The improved 10-step…”
Get full text
Journal Article -
8
Influence of a Basic Side Chain on the Properties of Hypoxia-Selective Nitro Analogues of the Duocarmycins: Demonstration of Substantial Anticancer Activity in Combination with Irradiation or Chemotherapy
Published in Journal of medicinal chemistry (13-07-2017)“…A new series of nitro analogues of the duocarmycins was prepared and evaluated for hypoxia-selective anticancer activity. The compounds incorporate 13…”
Get full text
Journal Article -
9
Hypoxia-Selective Antitumor Agents. 12. Nitrobenzyl Quaternary Salts as Bioreductive Prodrugs of the Alkylating Agent Mechlorethamine
Published in Journal of medicinal chemistry (01-03-1996)“…A series of benzene-substituted analogues of the novel hypoxia-selective cytotoxin N,N-bis(2-chloroethyl)-N-methyl-N-(2-nitrobenzyl)ammonium chloride (3a),…”
Get full text
Journal Article -
10
Antibody–Drug Conjugates Derived from Cytotoxic seco-CBI-Dimer Payloads Are Highly Efficacious in Xenograft Models and Form Protein Adducts In Vivo
Published in Bioconjugate chemistry (15-05-2019)“…This work discloses the first examples of antibody–drug conjugates (ADCs) that are constructed from linker-drugs bearing dimeric seco-CBI payloads (duocarmycin…”
Get full text
Journal Article -
11
Cross-Bridged Cyclen or Cyclam Co(III) Complexes Containing Cytotoxic Ligands as Hypoxia-Activated Prodrugs
Published in Inorganic chemistry (01-07-2013)“…A series of cobalt(III) complexes of the potent DNA minor groove alkylator…”
Get full text
Journal Article -
12
Analogues of DNA minor groove cross-linking agents incorporating aminoCBI, an amino derivative of the duocarmycins: Synthesis, cytotoxicity, and potential as payloads for antibody-drug conjugates
Published in Bioorganic & medicinal chemistry (15-11-2016)“…A Pd-catalysed amination method is used to convert seco-CBI, a synthetic analogue of the alkylating subunit of the duocarmycin natural products, from the…”
Get full text
Journal Article -
13
Nitro seco Analogues of the Duocarmycins Containing Sulfonate Leaving Groups as Hypoxia-Activated Prodrugs for Cancer Therapy
Published in Journal of medicinal chemistry (22-03-2012)“…The synthesis of 19 (5-nitro-2,3-dihydro-1H-benzo[e]indol-1-yl)methyl sulfonate prodrugs containing sulfonate leaving groups and 7-substituted…”
Get full text
Journal Article -
14
The flavoprotein FOXRED2 reductively activates nitro-chloromethylbenzindolines and other hypoxia-targeting prodrugs
Published in Biochemical pharmacology (15-05-2014)“…The nitro-chloromethylbenzindoline prodrug SN29428 has been rationally designed to target tumour hypoxia. SN29428 is metabolised to a DNA minor groove…”
Get full text
Journal Article -
15
The Cytotoxicity of Duocarmycin Analogues is Mediated through Alkylation of DNA, not Aldehyde Dehydrogenase 1: A Comment
Published in Angewandte Chemie International Edition (17-05-2013)“…The answer lies in the DNA: Recent claims that the alkylation of a particular protein contributes to the cytotoxicity of the duocarmycins could not be…”
Get full text
Journal Article -
16
Nitrobenzyl mustard quaternary salts: a new class of hypoxia-selective cytotoxins showing very high in vitro selectivity
Published in Journal of medicinal chemistry (01-08-1993)Get full text
Journal Article -
17
Selective Treatment of Hypoxic Tumor Cells In Vivo: Phosphate Pre-Prodrugs of Nitro Analogues of the Duocarmycins
Published in Angewandte Chemie (International ed.) (07-03-2011)“…Hitting the hypoxic target: Combining a nitro prodrug with a water‐soluble phosphate converts duocarmycin analogues from highly toxic DNA‐alkylating agents to…”
Get full text
Journal Article -
18
Tyrosine kinase inhibitors. 1. Structure-activity relationships for inhibition of epidermal growth factor receptor tyrosine kinase activity by 2,3-dihydro-2-thioxo-1H-indole-3-alkanoic acids and 2,2'-dithiobis(1H-indole-3-alkanoic acids)
Published in Journal of medicinal chemistry (01-08-1993)“…A series of 2,3-dihydro-2-thioxo-1H-indole-3-alkanoic acids, and their methyl esters were prepared, the majority by oxidation of 1H-indole-3-alkanoic acids…”
Get full text
Journal Article -
19
Hypoxia-Activated Prodrugs: Substituent Effects on the Properties of Nitro seco-1,2,9,9a-Tetrahydrocyclopropa[c]benz[e]indol-4-one (nitroCBI) Prodrugs of DNA Minor Groove Alkylating Agents
Published in Journal of medicinal chemistry (26-11-2009)“…Nitrochloromethylbenzindolines (nitroCBIs) are a new class of hypoxia-activated prodrugs for antitumor therapy. The recently reported prototypes undergo…”
Get full text
Journal Article -
20
A new enantioselective approach to the core structure of hypoxia selective prodrugs related to the duocarmycins
Published in Tetrahedron letters (21-12-2011)“…The indoline scaffold of hypoxia selective prodrugs of DNA-alkylating agents related to the duocarmycin natural products was synthesized via an…”
Get full text
Journal Article